Zenith's Generic Nizatidine Approval Delayed Until End Of Litigation With Lilly
Executive Summary
Zenith Goldline's generic nizatidine will not receive full FDA approval until the conclusion of patent litigation with Lilly, following a March 8 court order which extends the 30 month stay of approval for the generic.